AML Treatment Selection: Goals, Tests, and Considerations

Cole McCoy, PharmD, and James McCloskey, MD, explain common treatment goals, cytogenetic tests, and considerations that factor into choosing individualized treatment for patients with AML.

EP: 1.What Does an AML Diagnosis Mean?

Now Viewing

EP: 2.AML Treatment Selection: Goals, Tests, and Considerations

EP: 3.Recent Treatment Updates for Managing Patients With AML

EP: 4.Determining Intensive Chemotherapy Eligibility in AML

AML Treatment Selection: Goals, Tests, and Considerations

EP: 1.What Does an AML Diagnosis Mean?

EP: 2.AML Treatment Selection: Goals, Tests, and Considerations

EP: 3.Recent Treatment Updates for Managing Patients With AML

EP: 4.Determining Intensive Chemotherapy Eligibility in AML

EP: 5.First-Line Treatment Options and Genetic Mutations

EP: 6.Assessing Clinical Trials and First-Line AML Treatment Options

EP: 7.A Care Team’s Individual Roles When Treating AML

EP: 8.Evaluating Patients and Novel Agents for AML Maintenance Therapy

EP: 9.Additional Agents for AML Maintenance Therapy

EP: 10.Data Supporting the Use of Maintenance Therapy in AML

EP: 11.Oral AML Maintenance Therapy Options

EP: 12.How Maintenance Therapy Has Impacted AML Treatment

EP: 13.Treating Relapsed/Refractory AML

EP: 14.The Future of Treating AML